Cephalexin Powder, For Suspension
Product Images NDC 63187-205

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 63187-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cephalexin Structural Formula (4d9aa03f C465 4dd2 B361 70f46ca77770 01)

Cephalexin Structural Formula (4d9aa03f C465 4dd2 B361 70f46ca77770 01)
Chemical structure of Cephalexin, depicting its molecular arrangement including a beta-lactam ring, side chains, and associated atoms.*
FDA Label Image

63187-205 (4d9aa03f C465 4dd2 B361 70f46ca77770 05)

63187-205 (4d9aa03f C465 4dd2 B361 70f46ca77770 05)
Cephalexin 250 mg/5 mL oral suspension powder, 100 mL bottle, labeled by Proficient Rx LP. The label states each 5 mL contains cephalexin monohydrate equivalent to 250 mg cephalexin. Manufactured by Teva Pharmaceuticals USA, Inc. Directions include storage at controlled room temperature and a caution to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.